BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 35179662)

  • 21. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute respiratory distress syndrome associated with macrophage activation syndrome in systemic lupus erythematosus: A case report and literature review.
    Chang ES; Yu HH; Wu CE; Chan TM
    Medicine (Baltimore); 2022 Feb; 101(5):e28612. PubMed ID: 35119005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.
    Borgia RE; Gerstein M; Levy DM; Silverman ED; Hiraki LT
    Arthritis Rheumatol; 2018 Apr; 70(4):616-624. PubMed ID: 29342508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review.
    Vilaiyuk S; Sirachainan N; Wanitkun S; Pirojsakul K; Vaewpanich J
    Clin Rheumatol; 2013 Jun; 32(6):899-904. PubMed ID: 23483294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease Flare of Systemic Lupus Erythematosus in Patients With Endstage Renal Disease on Dialysis.
    Kim YE; Choi SJ; Lim DH; Kim H; Ahn SM; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    J Rheumatol; 2022 Oct; 49(10):1131-1137. PubMed ID: 35970534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
    Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
    Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.
    Lin Q; Zhang M; Tang H; Shen Y; Zhu Y; Xu Q; Li X
    Rheumatol Int; 2020 May; 40(5):811-819. PubMed ID: 31377830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature.
    Heijstek V; Habib M; van der Palen R; van Doorn R; Muller PH
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):13. PubMed ID: 33568193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature.
    Aziz A; Castaneda EE; Ahmad N; Veerapalli H; Rockferry AG; Lankala CR; Hamid P
    Cureus; 2021 Oct; 13(10):e18822. PubMed ID: 34804679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
    Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
    Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: a case-control study and literature review.
    Kim JM; Kwok SK; Ju JH; Kim HY; Park SH
    J Rheumatol; 2012 Jan; 39(1):86-93. PubMed ID: 22174206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage Activation Syndrome.
    Sen ES; Clarke SL; Ramanan AV
    Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis.
    Phoophiboon V; Brown P; Burns KEA
    Can J Anaesth; 2023 Jul; 70(7):1255-1260. PubMed ID: 37349668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics and treatment outcomes of macrophage activation syndrome in adults: A case series of 67 patients].
    Yao HH; Wang YN; Zhang X; Zhao JX; Jia Y; Wang Z; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):996-1002. PubMed ID: 31848493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
    Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
    Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
    Kübler L; Bittmann I; Kuipers JG
    Z Rheumatol; 2020 Dec; 79(10):1040-1045. PubMed ID: 32804304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical analysis of macrophage activation syndrome in adult rheumatic disease: A multicenter retrospective study.
    Ke Y; Lv C; Xuan W; Wu J; Da Z; Wei H; Zhang M; Tan W
    Int J Rheum Dis; 2020 Nov; 23(11):1488-1496. PubMed ID: 32885598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.